Literature DB >> 25418753

Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever.

Ana C V Oliveira1, Licia M H Mota, Leopoldo L Santos-Neto, Marisol Simões, Olindo A Martins-Filho, Pedro L Tauil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25418753     DOI: 10.1002/art.38960

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  11 in total

1. 

Authors:  Norbert Wagner; Frauke Assmus; Gabriele Arendt; Erika Baum; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Dirk Föll; Edeltraut Garbe; Jane Hecht; Ulf Müller-Ladner; Tim Niehues; Klaus Überla; Sabine Vygen-Bonnet; Thomas Weinke; Miriam Wiese-Posselt; Michael Wojcinski; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

2.  Seroconversion of rheumatoid arthritis patients after yellow fever vaccination.

Authors:  Betina Soares Dos Reis; Felipe Cintra Staub; Andrea Koishi; Camila Zanluca; Claudia Nunes Duarte Dos Santos; Thelma L Skare; Bárbara Stadler Kahlow
Journal:  Clin Rheumatol       Date:  2021-10-21       Impact factor: 2.980

3.  Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.

Authors:  Ismael Artur da Costa-Rocha; Ketty Lysie Libardi Lira Machado; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Sheila Maria Barbosa de Lima; Emily Hime Miranda; Gisela Freitas Trindade; Thays Zanon Casagrande; Samira Tatiyama Miyamoto; Sávio Carvalho Deotti; Rafaela Villa Real Barbosa; Priscila Costa Martins Rocha; Erica Vieira Serrano; Valquiria Garcia Dinis; Sônia Alves Gouvêa; Maria Bernadete Renoldi de Oliveira Gavi; Lidia Balarini da Silva; Ruben Horst Duque; Ana Paula Espíndula Gianordoli; Maria de Fatima Bissoli; Maria da Penha Gomes Gouvea; Lauro Ferreira da Silva Pinto-Neto; Ana Paula Neves Burian; Francieli Fontana Sutile Tardetti Fantinato; Gecilmara Salviato Pileggi; Licia Maria Henrique da Mota; Valéria Valim; Olindo Assis Martins-Filho
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

4.  Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Cutan Med Surg       Date:  2018-11-21       Impact factor: 2.092

5.  Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Authors:  Christien Rondaan; Victoria Furer; Marloes W Heijstek; Nancy Agmon-Levin; Marc Bijl; Ferdinand C Breedveld; Raffaele D'Amelio; Maxime Dougados; Meliha C Kapetanovic; Jacob M van Laar; Annette Ladefoged de Thurah; Robert Landewé; Anna Molto; Ulf Müller-Ladner; Karen Schreiber; Leo Smolar; Jim Walker; Klaus Warnatz; Nico M Wulffraat; Sander van Assen; Ori Elkayam
Journal:  RMD Open       Date:  2019-09-09

Review 6.  An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.

Authors:  Louise M Gresham; Barbara Marzario; Jan Dutz; Mark G Kirchhof
Journal:  J Am Acad Dermatol       Date:  2021-01-19       Impact factor: 11.527

7.  Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases.

Authors:  Nádia Emi Aikawa; Verena Andrade Balbi; Eduardo Ferreira Borba; Adriana Coracini Tonacio; Adriana Maluf Elias Sallum; Lucia Maria Arruda Campos; Kátia Tomie Kozu; Margarete Borges Vendramini; Nicole Fontoura; Adriana de Souza Azevedo; Waleska Dias Schwarcz; Ana Marli Christovam Sartori; Leila Antonangelo; Clovis Artur Silva; Eloisa Bonfá
Journal:  Vaccine X       Date:  2021-12-10

8.  Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.

Authors:  Adriana Coracini Tonacio; Tatiana do Nascimento Pedrosa; Eduardo Ferreira Borba; Nadia Emi Aikawa; Sandra Gofinet Pasoto; Júlio Cesar Rente Ferreira Filho; Marília Mantovani Sampaio Barros; Elaine Pires Leon; Suzete Cleusa Ferreira Spina Lombardi; Alfredo Mendrone Junior; Adriana de Souza Azevedo; Waleska Dias Schwarcz; Ricardo Fuller; Emily Figueiredo Neves Yuki; Michelle Remião Ugolini Lopes; Rosa Maria Rodrigues Pereira; Percival Degrava Sampaio Barros; Danieli Castro Oliveira de Andrade; Ana Cristina de Medeiros-Ribeiro; Julio Cesar Bertacini de Moraes; Samuel Katsuyuki Shinjo; Renata Miossi; Alberto José da Silva Duarte; Marta Heloisa Lopes; Esper Georges Kallás; Clovis Artur Almeida da Silva; Eloisa Bonfá
Journal:  PLoS Negl Trop Dis       Date:  2021-11-29

Review 9.  Primary vaccine failure to routine vaccines: Why and what to do?

Authors:  Ursula Wiedermann; Erika Garner-Spitzer; Angelika Wagner
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

10.  Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.

Authors:  Valéria Valim; Ketty Lysie Libardi Lira Machado; Samira Tatiyama Miyamoto; Arthur Dalmaso Pinto; Priscila Costa Martins Rocha; Erica Vieira Serrano; Valquiria Garcia Dinis; Sônia Alves Gouvêa; João Gabriel Fragoso Dias; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Ismael Artur da Costa-Rocha; Sheila Maria Barbosa de Lima; Emily Hime Miranda; Gisela Freitas Trindade; Maria de Lourdes de Sousa Maia; Maria Bernadete Renoldi de Oliveira Gavi; Lidia Balarini da Silva; Ruben Horst Duque; Ana Paula Espíndula Gianordoli; Thays Zanon Casagrande; Karine Gadioli Oliveira; Bruna Costa da Mata Moura; Fernanda Nicole-Batista; Luiza Correa Rodrigues; Thalles Brandão Clemente; Enan Sales Magalhães; Maria de Fatima Bissoli; Maria da Penha Gomes Gouvea; Lauro Ferreira da Silva Pinto-Neto; Carolina Zorzanelli Costa; Raquel Altoé Giovelli; Leticia Resende Brandão; Elizandra Tomazela Laurenti Polito; Ingrid de Oliveira Koehlert; Brunela Passos Borjaille; Daniela Bergamim Pereira; Laiza Hombre Dias; Daniela Linhares Merlo; Luiz Fellipe Favoreto Genelhu; Flavia Zon Pretti; Maryella Dos Santos Giacomin; Ana Paula Neves Burian; Francieli Fontana Sutile Tardetti Fantinato; Gecilmara Salviato Pileggi; Lícia Maria Henrique da Mota; Olindo Assis Martins-Filho
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.